A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant nigerian women

American Journal of Tropical Medicine and Hygiene

Volumn 76, Issue 6, 2007, Pages 1019-1023

  Tukur, Ibrahim U ^b   Thacher, Tom D ^a   Sagay, Atiene S ^a   Madaki, Jeremiah K A ^a  

^a UNIVERSITY OF JOS   (Nigeria)

^b State House Clinic   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FERROUS SULFATE; FOLIC ACID; PROMETHAZINE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; FANSIDAR; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DIZZINESS; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HUMAN; INFECTION PREVENTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; NIGERIA; PARASITEMIA; PREGNANCY; PREGNANT WOMAN; PRURITUS; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT; VOMITING; ANIMAL; BIRTH WEIGHT; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HEMATOCRIT; MALARIA FALCIPARUM; NEWBORN; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREGNANCY COMPLICATION;

ADULT; ANIMALS; ANTIMALARIALS; BIRTH WEIGHT; CHLOROQUINE; DRUG COMBINATIONS; FEMALE; HEMATOCRIT; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; NIGERIA; PARASITEMIA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

EID: 34548043044     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.76.1019     Document Type: Article

References (26)

1. Diagne N, Rogier C, Sokhna CS, Tall A, Fontenille D, Roussilhon C, Spiegel A, Trape JF, 2000. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 343: 598-603.
2. Anya SE, 2004. Seasonal variation in the risk and causes of maternal death in The Gambia: malaria appears to be an important factor. Am J Trop Med Hyg 70: 510-513.
3. van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U, 2004. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 71: 35-40.
4. Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RF, 2005. Risk factors for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg 72: 236-242.
5. 2004. National Guidelines and Strategies for Malaria Prevention and Control during Pregnancy. Lagos: Federal Ministry of Health, Nigeria, 31.
6. Steketee RW, Wirima JJ, Campbell CC, 1996. Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg 55: 95-100.
7. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
8. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K, 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353: 632-636.
9. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL, 1998. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92: 141-150.
10. Newman RD, Moran AC, Kayentao K, Benga-De E, Yameogo M, Gaye O, Faye O, Lo Y, Moreira PM, Doumbo O, Parise ME, Steketee RW, 2006. Prevention of malaria during pregnancy in west Africa: policy change and the power of subregional action. Trop Med Int Health 11: 462-469.
11. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW, 1998. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59: 813-822.
12. Steketee RW, Wirima JJ, Bioland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG, 1996. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55: 42-49.
13. Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, Lema VM, Molyneux ME, Meshnick SR, Rogerson SJ, 2004. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 363: 1860-1867.
14. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C, Kolczak MS, Otieno JA, Misore AO, Kager PA, Lal RB, Steketee RW, Nahlen BL, 2004. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 10: 643-652.
15. Sowunmi A, Fateye BA, 2003. Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites. Ann Trop Med Parasitol 97: 469-479.
16. Olumese PE, Amodu OK, Bjorkman A, Adeyemo AA, Gbadegesin RA, Walker O, 2002. Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg 96: 418-420.
17. Ogunbode O, Adewuyi J, Okwerekwu F, Awarun JA, 1991. Chemoprophylaxis during pregnancy in malaria endemic areas: practical considerations. Trop J Obstet Gynaecol 9: 31-34.
18. Nyirjesy P, Kavasya T, Axelrod P, Fischer PR, 1993. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis 16: 127-132.
19. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, Jha P, Musgrove P, Chow J, Shahid-Salles S, Jamison DT, 2006. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 367: 1193-1208.
20. Nahlen BL, Akintunde A, Alakija T, Nguyen-Dinh P, Ogunbode O, Edungbola LD, Adetoro O, Breman JG, 1989. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet 2: 830-834.
21. Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS, Maiga B, Mungai M, Parise ME, Doumbo O, 2005. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 191: 109-116.
22. Sirima SB, Cotte AH, Konate A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouedraogo A, Parise ME, Newman RD, 2006. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Am J Trop Med Hyg 75: 205-211.
23. Sirima SB, Sawadogo R, Moran AC, Konate A, Diarra A, Yameogo M, Parise ME, Newman RD, 2003. Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela District, Burkina Faso. Clin Infect Dis 36: 1374-1382.
24. Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, Walraven G, 2006. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Trop Med Int Health 11: 992-1002.
25. Coulibaly SO, Nezien D, Traore S, Kone B, 2006. Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Malar J 5: 49.
26. Pitmang SL, Thacher TD, Madaki JK, Egah DZ, Fischer PR, 2005. Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria. Am J Trop Med Hyg 72: 263-266.